Prospective Study
Copyright ©The Author(s) 2024.
World J Gastrointest Endosc. May 16, 2024; 16(5): 259-272
Published online May 16, 2024. doi: 10.4253/wjge.v16.i5.259
Table 6 Subgroup analyses for biopsy pathology improved (intention-to-treat population)
Subgroup
Number (n)
Rate (%)
HR (95%CI)
P value
Male (n = 100)0.043
Conventional group (n = 49)48.161.00
Experimental group (n = 51)1121.573.285 (1.040, 10.375)
Female (n = 66)0.227
Conventional group (n = 31)39.681.00
Experimental group (n = 35)617.142.356 (0.587, 9.449)
Age > 60 (n = 82)0.035
Conventional group (n = 42)49.521.00
Experimental group (n = 40)922.503.609 (1.091, 11.933)
Age ≤ 60 (n = 84)0.187
Conventional group (n = 38)37.891.00
Experimental group (n = 46)817.392.444 (0.648, 9.216)
Lesion size ≤ 0.5 cm (n = 119)0.042
Conventional group (n = 54)35.561.00
Experimental group (n = 65)1421.543.199 (1.042, 9.820)
Lesion size > 0.5cm (n = 47)0.214
Conventional group (n = 26)415.381.00
Experimental group (n = 21)314.292.626 (0.573, 12.033)
Lesion in upper thoracic esophagus (n = 20)0.440
Conventional group (n = 8)112.501.00
Experimental group (n = 12)216.672.610 (0.229, 29.702)
Lesion in middle thoracic esophagus (n = 96)0.108
Conventional group (n = 52)59.621.00
Experimental group (n = 44)818.182.510 (0.817, 7.708)
Lesion in lower thoracic esophagus (n = 50)0.112
Conventional group (n = 20)15.001.00
Experimental group (n = 30)723.335.485 (0.673, 44.705)
Undergone esophageal ESD previously (n = 65)0.088
Conventional group (n = 29)26.901.00
Experimental group (n = 36)513.894.462 (0.799, 24.917)
Not undergone esophageal ESD previously (n = 101)0.135
Conventional group (n = 51)59.801.00
Experimental group (n = 50)1224.002.198 (0.783, 6.171)
Lesion biopsy: Squamous epithelial hyperplasia (n = 151)0.056
Conventional group (n = 74)56.761.00
Experimental group (n = 77)1114.292.820 (0.974, 8.161)
Lesion biopsy: Low grade intraepithelial neoplasia (n = 15)0.342
Conventional group (n = 6)233.331.00
Experimental group (n = 9)666.672.184 (0.436, 10.936)